Pfizer has announced its coronavirus vaccine candidate is more than 90 per cent effective in preventing COVID-19 infection.
Read More »
Pfizer has announced its coronavirus vaccine candidate is more than 90 per cent effective in preventing COVID-19 infection.
Read More »AstraZeneca says it's encouraged by "incredibly promising" COVID-19 vaccine trial data unveiled by Pfizer and German partner BioNTech. Speaking at a
Read More »It looks set to be a fantastic day for the S&P/ASX 200 Index (ASX:XJO) on Tuesday after strong results from Pfizer's COVID-19 vaccine
Read More »A vaccine jointly developed by Pfizer and BioNTech is said to have been almost 90 percent effective in preventing Covid-19 infections, according to the preliminary findings by the companies, but with a catch – the medicines need to be stored at extra …
Read More »The coronavirus vaccine candidate developed by US pharma giant Pfizer together with Germany's BioNTech is 90 per cent effective in preventing COVID-19, the
Read More »Senior British government sources reportedly expect a verdict on whether a Pfizer Inc-backed COVID-19 vaccine works will be available before the results are
Read More »Pfizer said on Friday it may file for authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, making it unlikely a vaccine will be available before U.S. elections as President Donald Trump has promised.
Read More »US pharmaceutical giant Pfizer expects to file for emergency use authorization for its Covid-19 vaccine in late November, around two weeks after the November 3 US presidential election, it said Friday.
Read More »